Melissa J Armstrong1,2, Slande Alliance1, Pamela Corsentino3, Susan M Maixner4, Henry L Paulson5, Angela Taylor3. 1. Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA. 2. McKnight Brain Institute, University of Florida, Gainesville, FL, USA. 3. Lewy Body Dementia Association, Lilburn, GA, USA. 4. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. 5. Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Abstract
OBJECTIVE: This study investigated barriers to quality end-of-life (EOL) care in the context of dementia with Lewy bodies (DLB), one of the most common degenerative dementias in the United States. METHODS: The study consisted of telephone interviews with caregivers and family members of individuals who died with DLB in the last 5 years. Interviews used a semi-structured questionnaire. Investigators employed a qualitative descriptive approach to analyze interview transcripts and identify common barriers to quality EOL care. RESULTS: Thirty participants completed interviews. Reported barriers to quality EOL experiences in DLB pertained to the DLB diagnosis itself and factors relating to the US health-care system, facilities, hospice, and health-care providers (physicians and staff). Commonly reported barriers included lack of recognition and knowledge of DLB, lack of education regarding what to expect, poor coordination of care and communication across health-care teams and circumstances, and difficulty accessing health-care resources including skilled nursing facility placement and hospice. CONCLUSION: Many identified themes were consistent with published barriers to quality EOL care in dementia. However, DLB-specific EOL considerations included diagnostic challenges, lack of knowledge regarding DLB and resultant prescribing errors, difficulty accessing resources due to behavioral changes in DLB, and waiting to meet Medicare dementia hospice guidelines. Improving EOL experiences in DLB will require a multifaceted approach, starting with improving DLB recognition and provider knowledge. More research is needed to improve recognition of EOL in DLB and factors that drive quality EOL experiences.
OBJECTIVE: This study investigated barriers to quality end-of-life (EOL) care in the context of dementia with Lewy bodies (DLB), one of the most common degenerative dementias in the United States. METHODS: The study consisted of telephone interviews with caregivers and family members of individuals who died with DLB in the last 5 years. Interviews used a semi-structured questionnaire. Investigators employed a qualitative descriptive approach to analyze interview transcripts and identify common barriers to quality EOL care. RESULTS: Thirty participants completed interviews. Reported barriers to quality EOL experiences in DLB pertained to the DLB diagnosis itself and factors relating to the US health-care system, facilities, hospice, and health-care providers (physicians and staff). Commonly reported barriers included lack of recognition and knowledge of DLB, lack of education regarding what to expect, poor coordination of care and communication across health-care teams and circumstances, and difficulty accessing health-care resources including skilled nursing facility placement and hospice. CONCLUSION: Many identified themes were consistent with published barriers to quality EOL care in dementia. However, DLB-specific EOL considerations included diagnostic challenges, lack of knowledge regarding DLB and resultant prescribing errors, difficulty accessing resources due to behavioral changes in DLB, and waiting to meet Medicare dementia hospice guidelines. Improving EOL experiences in DLB will require a multifaceted approach, starting with improving DLB recognition and provider knowledge. More research is needed to improve recognition of EOL in DLB and factors that drive quality EOL experiences.
Entities:
Keywords:
Lewy body disease; death; dementia with Lewy bodies; health-care quality; hospice care; palliative care; qualitative research; terminal care
Authors: Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara Journal: Alzheimer Dis Assoc Disord Date: 2002 Oct-Dec Impact factor: 2.703
Authors: James E Galvin; John E Duda; Daniel I Kaufer; Carol F Lippa; Angela Taylor; Steven H Zarit Journal: Parkinsonism Relat Disord Date: 2010-07 Impact factor: 4.891
Authors: Alexia M Torke; Laura R Holtz; Siu Hui; Peter Castelluccio; Stephen Connor; Matthew A Eaton; Greg A Sachs Journal: J Am Geriatr Soc Date: 2010-11 Impact factor: 5.562
Authors: Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka Journal: Neurology Date: 2017-06-07 Impact factor: 9.910
Authors: Kim Beernaert; Luc Deliens; Koen Pardon; Lieve Van den Block; Dirk Devroey; Kenneth Chambaere; Joachim Cohen Journal: PLoS One Date: 2015-09-10 Impact factor: 3.240
Authors: Nuriye Kupeli; Gerard Leavey; Kirsten Moore; Jane Harrington; Kathryn Lord; Michael King; Irwin Nazareth; Elizabeth L Sampson; Louise Jones Journal: BMC Palliat Care Date: 2016-03-10 Impact factor: 3.234
Authors: Nathan Davies; Laura Maio; Krish Vedavanam; Jill Manthorpe; Myrra Vernooij-Dassen; Steve Iliffe Journal: Health Soc Care Community Date: 2013-12-27
Authors: Annabel Price; Redwan Farooq; Jin-Min Yuan; Vandana B Menon; Rudolf N Cardinal; John T O'Brien Journal: BMJ Open Date: 2017-11-03 Impact factor: 2.692
Authors: Jacob D Hill; Claire De Forcrand; Allison M Cuthel; Oluwaseun John Adeyemi; Amanda J Shallcross; Corita R Grudzen Journal: PLoS One Date: 2022-08-05 Impact factor: 3.752